June 21, 2017

In 2009, a handful of CBD-rich cannabis strains were discovered serendipitously in Northern California, America’s cannabis breadbasket, where certified patients could access medical marijuana legally. Thus began a great laboratory experiment in democracy involving CBD-rich cannabis therapeutics. The advent of whole plant CBD-rich oil as a grassroots therapeutic option has changed the national conversation about […]

In 2009, a handful of CBD-rich cannabis strains were discovered serendipitously in Northern California, America’s cannabis breadbasket, where certified patients could access medical marijuana legally. Thus began a great laboratory experiment in democracy involving CBD-rich cannabis therapeutics. The advent of whole plant CBD-rich oil as a grassroots therapeutic option has changed the national conversation about […]

TORONTO (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (“WeedMD” or the “Company”), a federally licensed producer of medical cannabis, is pleased to announce that on June 16, 2017, the Company received a supplemental license from Health Canada for the production of medical cannabis oils. The Company has imported a purpose-built high-throughput ethanol extraction machine from Germany, with the […]

TORONTO (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (“WeedMD” or the “Company”), a federally licensed producer of medical cannabis, is pleased to announce that on June 16, 2017, the Company received a supplemental license from Health Canada for the production of medical cannabis oils. The Company has imported a purpose-built high-throughput ethanol extraction machine from Germany, with the […]

AXIM Biotechnologies received $4 million in institutional funding to advance clinical trials for cannabis chewing gum for the treatment of irritable bowel syndrome (IBS) and pain and spasticity in multiple sclerosis (MS). The secured funds will also allow the company to continue its bioequivalency study.   The bioequivalency study seeks to develop the prototype chewing […]

AXIM Biotechnologies received $4 million in institutional funding to advance clinical trials for cannabis chewing gum for the treatment of irritable bowel syndrome (IBS) and pain and spasticity in multiple sclerosis (MS). The secured funds will also allow the company to continue its bioequivalency study.   The bioequivalency study seeks to develop the prototype chewing […]